Patients of the Cancer Institute have access to cutting-edge prevention strategies and cancer therapeutics through its clinical research program.
Cancer Clinical Trials and Regulatory Affairs (CCTRA)
The Cancer Clinical Trials and Regulatory Affairs (CCTRA) office assists investigators with clinical trial design, regulatory management and data management.
Disease Oriented Committees (DOCs)
The Disease Oriented Committees (DOCs) help cancer researchers identify clinical collaborators, work out feasibility issues, and brainstorm experimental and statistical design.
Protocol Review and Monitoring Committee
The Protocol Review and Monitoring Committee provides scientific review of all clinical research at the Cancer Institute and monitors human subject accrual to clinical trials. The Cancer Institute clinical trial portfolio includes therapeutic and prevention trials sponsored by peer-reviewed funding agencies, industry and National Cancer Institute Cooperative Groups.